Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2000 Jul;55(7):574–578. doi: 10.1136/thorax.55.7.574

Oestrogen metabolism in lymphangioleiomyomatosis: catechol-O-methyltransferase pathway is not involved

B Paquette 1, P Fortier 1, J Heroux 1, P Thibodeau 1, R Wagner 1, J Liu 1, A Cantin 1
PMCID: PMC1745813  PMID: 10856317

Abstract

BACKGROUND—Lymphangioleiomyomatosis (LAM) is an uncommon lung disease for which no effective method of treatment has been found. The predilection of LAM for premenopausal women has led to the assumption that hormonal factors play an important role in the pathogenesis of this disease. The aim of this study was to determine if women with LAM manifest alterations in the catechol-O-methyltransferase (COMT) pathway which is essential for preventing the generation of oestrogen derived reactive oxygen species (ROS).
METHODS—Blood samples were collected from 15 women with LAM and compared with appropriate controls. The distribution of high and low activity alleles of COMT was determined with a PCR based RFLP assay. The enzymatic activity of COMT was measured in each sample and the potential presence of a circulating inhibitor of COMT was determined. Since an alteration in the COMT pathway could increase the oxidative stress, the plasma concentration of malondialdehyde (MDA), a secondary product generated from lipid peroxidation, has been used as an internal marker.
RESULTS—The distribution of high and low activity alleles of COMT (named COMTHH, COMTLL, and COMTHL) was similar in the two groups with proportions of 40%, 7%, and 53%, respectively, in the women with LAM and 38%, 6%, and 56% in the control subjects. The mean (SD) COMT activity was 24.2(12.3) pmol/min/mg protein in women with LAM and 24.1 (6.3) pmol/min/mg protein in the control group. Incubation of plasma from women in the two groups with a preparation of commercial COMT showed that no detectable COMT inhibitor was present. The plasma concentration of MDA in the women with LAM was also not significantly different from control subjects.
CONCLUSIONS—This study shows that there are no significant alterations in the COMT pathway of women with LAM. It is therefore unlikely that alterations in oestrogen mediated cell signalling pathways are mediated by oxidants derived from an excess of catecholoestrogens in LAM.



Full Text

The Full Text of this article is available as a PDF (155.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abul-Hajj Y. J., Thijssen J. H., Blankenstein M. A. Metabolism of estradiol by human breast cancer. Eur J Cancer Clin Oncol. 1988 Jul;24(7):1171–1178. doi: 10.1016/0277-5379(88)90124-1. [DOI] [PubMed] [Google Scholar]
  2. Abul-Hajj Y. J., Thijssen J. H., Blankenstein M. A. Metabolism of estradiol by human breast cancer. Eur J Cancer Clin Oncol. 1988 Jul;24(7):1171–1178. doi: 10.1016/0277-5379(88)90124-1. [DOI] [PubMed] [Google Scholar]
  3. Boehler A., Speich R., Russi E. W., Weder W. Lung transplantation for lymphangioleiomyomatosis. N Engl J Med. 1996 Oct 24;335(17):1275–1280. doi: 10.1056/NEJM199610243351704. [DOI] [PubMed] [Google Scholar]
  4. Bonetti F., Chiodera P. L., Pea M., Martignoni G., Bosi F., Zamboni G., Mariuzzi G. M. Transbronchial biopsy in lymphangiomyomatosis of the lung. HMB45 for diagnosis. Am J Surg Pathol. 1993 Nov;17(11):1092–1102. doi: 10.1097/00000478-199311000-00002. [DOI] [PubMed] [Google Scholar]
  5. Farhat M. Y., Vargas R., Dingaan B., Ramwell P. W. In vitro effect of oestradiol on thymidine uptake in pulmonary vascular smooth muscle cell: role of the endothelium. Br J Pharmacol. 1992 Nov;107(3):679–683. doi: 10.1111/j.1476-5381.1992.tb14506.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gulliver P. A., Tipton K. F. Direct extraction radioassay for catechol-Q-methyl-transferase activity. Biochem Pharmacol. 1978 Mar 1;27(5):773–775. doi: 10.1016/0006-2952(78)90519-1. [DOI] [PubMed] [Google Scholar]
  7. Kalassian K. G., Doyle R., Kao P., Ruoss S., Raffin T. A. Lymphangioleiomyomatosis: new insights. Am J Respir Crit Care Med. 1997 Apr;155(4):1183–1186. doi: 10.1164/ajrccm.155.4.9105053. [DOI] [PubMed] [Google Scholar]
  8. Khan A. U., Wilson T. Reactive oxygen species as cellular messengers. Chem Biol. 1995 Jul;2(7):437–445. doi: 10.1016/1074-5521(95)90259-7. [DOI] [PubMed] [Google Scholar]
  9. Kitaichi M., Nishimura K., Itoh H., Izumi T. Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):527–533. doi: 10.1164/ajrccm.151.2.7842216. [DOI] [PubMed] [Google Scholar]
  10. Kobzik L., Bredt D. S., Lowenstein C. J., Drazen J., Gaston B., Sugarbaker D., Stamler J. S. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol. 1993 Oct;9(4):371–377. doi: 10.1165/ajrcmb/9.4.371. [DOI] [PubMed] [Google Scholar]
  11. Lavigne J. A., Helzlsouer K. J., Huang H. Y., Strickland P. T., Bell D. A., Selmin O., Watson M. A., Hoffman S., Comstock G. W., Yager J. D. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res. 1997 Dec 15;57(24):5493–5497. [PubMed] [Google Scholar]
  12. Li S. A., Purdy R. H., Li J. J. Variations in catechol O-methyltransferase activity in rodent tissues: possible role in estrogen carcinogenicity. Carcinogenesis. 1989 Jan;10(1):63–67. doi: 10.1093/carcin/10.1.63. [DOI] [PubMed] [Google Scholar]
  13. Liehr J. G., Ricci M. J. 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3294–3296. doi: 10.1073/pnas.93.8.3294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Moorhouse C. P., Halliwell B., Grootveld M., Gutteridge J. M. Cobalt(II) ion as a promoter of hydroxyl radical and possible 'crypto-hydroxyl' radical formation under physiological conditions. Differential effects of hydroxyl radical scavengers. Biochim Biophys Acta. 1985 Dec 13;843(3):261–268. doi: 10.1016/0304-4165(85)90147-3. [DOI] [PubMed] [Google Scholar]
  15. Nine J. S., Yousem S. A., Paradis I. L., Keenan R., Griffith B. P. Lymphangioleiomyomatosis: recurrence after lung transplantation. J Heart Lung Transplant. 1994 Jul-Aug;13(4):714–719. [PubMed] [Google Scholar]
  16. O'Brien J. D., Lium J. H., Parosa J. F., Deyoung B. R., Wick M. R., Trulock E. P. Lymphangiomyomatosis recurrence in the allograft after single-lung transplantation. Am J Respir Crit Care Med. 1995 Jun;151(6):2033–2036. doi: 10.1164/ajrccm.151.6.7767554. [DOI] [PubMed] [Google Scholar]
  17. Raymond F. A., Weinshilboum R. M. Microassay of human erythrocyte catechol-O-methyltransferase: removal of inhibitory calcium ion with chelating resin. Clin Chim Acta. 1975 Jan 20;58(2):185–194. doi: 10.1016/s0009-8981(75)80012-x. [DOI] [PubMed] [Google Scholar]
  18. Sundaresan M., Yu Z. X., Ferrans V. J., Irani K., Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science. 1995 Oct 13;270(5234):296–299. doi: 10.1126/science.270.5234.296. [DOI] [PubMed] [Google Scholar]
  19. Thibodeau P. A., Bissonnette N., Bédard S. K., Hunting D., Paquette B. Induction by estrogens of methotrexate resistance in MCF-7 breast cancer cells. Carcinogenesis. 1998 Sep;19(9):1545–1552. doi: 10.1093/carcin/19.9.1545. [DOI] [PubMed] [Google Scholar]
  20. Thibodeau P. A., Paquette B. DNA damage induced by catecholestrogens in the presence of copper (II): generation of reactive oxygen species and enhancement by NADH. Free Radic Biol Med. 1999 Dec;27(11-12):1367–1377. doi: 10.1016/s0891-5849(99)00183-5. [DOI] [PubMed] [Google Scholar]
  21. Thompson P. A., Shields P. G., Freudenheim J. L., Stone A., Vena J. E., Marshall J. R., Graham S., Laughlin R., Nemoto T., Kadlubar F. F. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res. 1998 May 15;58(10):2107–2110. [PubMed] [Google Scholar]
  22. Yager J. D., Liehr J. G. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol. 1996;36:203–232. doi: 10.1146/annurev.pa.36.040196.001223. [DOI] [PubMed] [Google Scholar]
  23. Yeo H. C., Helbock H. J., Chyu D. W., Ames B. N. Assay of malondialdehyde in biological fluids by gas chromatography-mass spectrometry. Anal Biochem. 1994 Aug 1;220(2):391–396. doi: 10.1006/abio.1994.1355. [DOI] [PubMed] [Google Scholar]
  24. Zhu B. T., Conney A. H. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis. 1998 Jan;19(1):1–27. doi: 10.1093/carcin/19.1.1. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES